Synthesis and radiolabeling of diabody fragment of anti-PD-L1-B11 antibody for PET imaging of PD-L1 in a melanoma tumor mouse model

被引:0
|
作者
Bansal, Aditya [1 ]
Lavoie, Roxane [1 ]
Lucien, Fabrice [1 ]
Kethamreddy, Manasa [1 ]
Dong, Haidong [1 ]
Park, Sean [1 ]
Pandey, Mukesh [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P-179
引用
收藏
页码:S193 / S194
页数:2
相关论文
共 50 条
  • [1] PET imaging of PD-L1 using anti-PD-L1-B11 antibody in breast cancer tumor model
    Bansal, Aditya
    Barham, Whitney
    Liu, Xin
    Harrington, Susan
    Lucien-Matteoni, Fabrice
    Dong, Haidong
    Park, Sean
    Pandey, Mukesh
    DeGrado, Timothy
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [2] Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models
    Bansal, Aditya
    Lavoie, Roxane R.
    Lucien, Fabrice
    Kethamreddy, Manasa
    Wootla, Bharath
    Dong, Haidong
    Park, Sean S.
    Pandey, Mukesh K.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model
    Bansal, Aditya
    Pandey, Mukesh K.
    Barham, Whitney
    Liu, Xin
    Harrington, Susan M.
    Lucien, Fabrice
    Dong, Haidong
    Park, Sean S.
    DeGrado, Timothy R.
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 100 : 4 - 11
  • [4] Preclinical antibody-PET imaging of PD-L1
    Brown, Emma L.
    Deweerd, Rachel A.
    Zidel, Abbey
    Pereira, Patricia M. R.
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 2
  • [5] HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC
    Funaishi, Kunihiko
    Yamaguchi, Kakuhiro
    Tanahashi, Hiroki
    Kurose, Koji
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Iwamoto, Hiroshi
    Hamada, Hironobu
    Oga, Toru
    Oka, Mikio
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [6] PET Imaging of PD-L1 Expression in NSCLC: Pharmacokinetic Comparison of an Antibody and its Fab Fragment
    Bouleau, A.
    Nozach, H.
    Richard, M.
    Dubois, S.
    Torquet, G.
    Kuhnast, B.
    Maillere, B.
    Lebon, V.
    Truillet, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S160 - S160
  • [7] Imaging of PD-L1 modulation by gemcitabine using 89Zr labeled anti-PD-L1 antibody PET.
    Jung, Kyung-Ho
    Park, Jin Won
    Lee, Jin Hee
    Cho, Young Seok
    Lee, Kyung-Han
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 90 - 91
  • [8] Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
    Heskamp, Sandra
    Hobo, Willemijn
    Molkenboer-Kuenen, Janneke D. M.
    Olive, Daniel
    Oyen, Wim J. G.
    Dolstra, Harry
    Boerman, Otto C.
    CANCER RESEARCH, 2015, 75 (14) : 2928 - 2936
  • [9] PET imaging of radiation-induced PD-L1 upregulation in the tumor microenvironment using a Zr-89 labeled PD-L1 monoclonal Ab in a mouse model
    Kikuchi, Masahiro
    Srivastava, Raghvendra
    Sun, Lingyi
    Zeng, Dexing
    Diaz-Perez, Julio
    Anderson, Carolyn
    Ferris, Robert
    Edwards, W. Barry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [10] Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Knapp, Deborah W.
    Lim, Seung-Oe
    MOLECULAR THERAPY, 2025, 33 (02)